These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1440273)

  • 21. Role of proteomics in the investigation of pulmonary fibrosis.
    Govender P; Baugh JA; Pennington SR; Dunn MJ; Donnelly SC
    Expert Rev Proteomics; 2007 Jun; 4(3):379-88. PubMed ID: 17552922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemical markers of inflammation and bronchial obstruction].
    Kulakova NV; Nevzorova VA; Luk'ianov PA; Gel'tser BI
    Klin Med (Mosk); 2000; 78(3):36-9. PubMed ID: 10790963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C.
    Idilman R; Cetinkaya H; Savaş I; Aslan N; Sak SD; Baştemir M; Sarioğlu M; Soykan I; Bozdayi M; Colantoni A; Aydintuğ O; Bahar K; Uzunalimoğlu O; Van Thiel DH; Numanoğlu N; Dökmeci A
    J Med Virol; 2002 Jan; 66(1):34-9. PubMed ID: 11748656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biogenic amines and acetylcholine in the bronchoalveolar lavage fluid of patients with chronic bronchitis].
    Goncharova VA; Molodtsova VP; Dotsenko EK
    Klin Med (Mosk); 1988 Dec; 66(12):41-3. PubMed ID: 3230848
    [No Abstract]   [Full Text] [Related]  

  • 26. [The level of biogenic amines in bronchi of patients with chronic obstructive bronchitis].
    Malakauskas KK; Goncharova VA; Aleksandrova NI
    Klin Med (Mosk); 1991 May; 69(5):60-3. PubMed ID: 1857081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proteolytic activities in bronchoalveolar lavage fluid in pneumonia and chronic bronchitis].
    Schmidt M; Heinrich J; Pfeifer M
    Pneumologie; 1990 Feb; 44 Suppl 1():308-9. PubMed ID: 2367400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cyto-oxidant markers of inflammation in assessing the efficacy of differentiating therapy of severe obstructive pulmonary diseases].
    Grinshteĭn IuI; Shestovitskiĭ VA; Kuligina-Maksimova AV; Cherkashina II; Aristov AI
    Klin Med (Mosk); 2003; 81(7):28-31. PubMed ID: 12934307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
    Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
    J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disorders of immune reactivity in chronic bronchitis].
    Shatalov NN; Kudriavitskiĭ AI; Smirnova VM; Rumiantseva EG; Ovchinnikov AA
    Ter Arkh; 1989; 61(3):54-7. PubMed ID: 2741119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hydroxyproline as an indicator of the process activity in inflammatory lung diseases].
    Iakushin SS; Shifrin MA
    Klin Med (Mosk); 1977 Dec; 55(12):65-9. PubMed ID: 604646
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytologic and certain cytoenzymologic characteristics of sputum in chronic nonspecific lung diseases].
    Kazantseva VM
    Arkh Patol; 1980; 42(4):63-8. PubMed ID: 7396757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhalative immunostimulation in patients with chronic bronchitis].
    Kaspar P; Petro W
    Z Hautkr; 1988; 63 Suppl 4():64-6. PubMed ID: 3075383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of pulmonary surfactant in the atherogenesis process in patients with dust-induced respiratory organ diseases].
    Korzh EV; Valutsina VM; Noreĭko SB
    Lik Sprava; 1994; (5-6):46-9. PubMed ID: 7831909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CHRONIC NON-SPECIFIC BRONCHOPATHIES. MEDICO-SOCIAL ASPECT AND EFFECTS OF THERAPY].
    TOUSSAINT P; TOUSSAINT-FRANCX Y; FLAMENT F; THEMELIN G; DEBOIS N
    Acta Tuberc Pneumol Belg; 1963; 54():304-25. PubMed ID: 14075945
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognosis in chronic bronchitis.
    Can Med Assoc J; 1968 Aug; 99(6):285. PubMed ID: 20329278
    [No Abstract]   [Full Text] [Related]  

  • 37. [The prognosis of the outcome of the inflammatory process in chronic bronchitis].
    Ubaĭdullaev AM; Liverko IV; Chernik MB
    Ter Arkh; 1992; 64(3):34-6. PubMed ID: 1440273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressive effect of anti-alpha 1-antichymotrypsin serum on pulmonary fibrosis induced by phorbol myristate acetate in vivo.
    Nagareda T; Tanaka A; Terada N; Imakon Y; Shiomi H; Matsubara H; Noro A; Nishizawa Y
    Lab Invest; 1995 Oct; 73(4):541-6. PubMed ID: 7474926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interleukin-6 and interleukin-8 in bronchoalveolar lavage fluid material from patients with chronic bronchitis].
    Jahnz-Rózyk K; Płusa T; Faber M; Stepnowski L; Pirozyńska E; Pojda Z
    Pol Merkur Lekarski; 1996 Dec; 1(6):383-5. PubMed ID: 9273226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The cytological characteristics of bronchoalveolar washings in chronic bronchitis].
    Grobova OM; Kop'eva TN; Makarova OV; Borisova AM; Dykhanov II; Makarova SA
    Probl Tuberk; 1989; (12):7-11. PubMed ID: 2628983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.